Neuroprotective effects of nimodipine and nifedipine in the NGF-differentiated PC12 cells exposed to oxygen-glucose deprivation or trophic withdrawal

International Journal of Developmental Neuroscience

Volumn 30, Issue 6, 2012, Pages 465-469

  Lecht, Shimon ^a   Rotfeld, Elena ^b   Arien Zakay, Hadar ^b   Tabakman, Rinat ^b   Matzner, Henry ^b   Yaka, Rami ^b   Lelkes, Peter I ^a   Lazarovici, Philip ^b  

^a DREXEL UNIVERSITY   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Hypocampal slices; Neuroprotection; Nifedipine; Nimodipine; Oxygen and glucose deprivation; PC12

Indexed keywords

CALCIUM CHANNEL L TYPE; CASPASE 3; LACTATE DEHYDROGENASE; NERVE GROWTH FACTOR; NIFEDIPINE; NIMODIPINE; RASAGILINE; TEMPOL;

ANIMAL TISSUE; ARTICLE; CELL HYPOXIA; CELL STRESS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; IN VITRO STUDY; ISCHEMIA; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPEUTIC TIME WINDOW; TIME;

ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; CASPASE 3; CATECHOLAMINES; CELL DIFFERENTIATION; CELL HYPOXIA; GLUCOSE; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENTS; NIFEDIPINE; NIMODIPINE; PC12 CELLS; RATS;

RATTUS;

EID: 84865864196     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2012.05.007     Document Type: Article

References (33)

1. Abu-Raya S., Bloch-Shilderman E., Lelkes P.I., Trembovler V., Shohami E., Gutman Y., Lazarovici P. Characterization of pardaxin-induced dopamine release from pheochromocytoma cells: role of calcium and eicosanoids. Journal of Pharmacology and Experimental Therapeutics 1999, 288:399-406.
2. Abu-Raya S., Tabakman R., Blaugrund E., Trembovler V., Lazarovici P. Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells. European Journal of Pharmacology 2002, 434:109-116.
3. Ahmed N., Nasman P., Wahlgren N.G. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 2000, 31:1250-1255.
4. Auriel E., Bornstein N.M. Neuroprotection in acute ischemic stroke - current status. Journal of Cellular and Molecular Medicine 2010, 14:2200-2202.
5. Babu C.S., Ramanathan M. Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics. International Journal of Developmental Neuroscience 2011, 29:93-105.
6. Barhwal K., Hota S.K., Baitharu I., Prasad D., Singh S.B., Ilavazhagan G. Isradipine antagonizes hypobaric hypoxia induced CA1 damage and memory impairment: complementary roles of l-type calcium channel and NMDA receptors. Neurobiology of Disease 2009, 34:230-244.
7. 2+ channel alpha 1-subunit transcripts are differentially expressed in rat pheochromocytoma (PC12) cells following nerve growth factor treatment. International Journal of Developmental Neuroscience 1998, 16:379-389.
8. Dispersyn G., Nuydens R., Borgers M., Geerts H. Nimodipine and flunarizine have different effects on survival and morphology of PC12 cells during nerve growth factor deprivation. European Journal of Pharmacology 1999, 384:61-70.
9. Duzenli S., Bakuridze K., Gepdiremen A. The effects of ruthenium red, dantrolene and nimodipine, alone or in combination, in NMDA induced neurotoxicity of cerebellar granular cell culture of rats. Toxicology In Vitro 2005, 19:589-594.
10. Ferrari G., Batistatou A., Greene L.A. Gangliosides rescue neuronal cells from death after trophic factor deprivation. Journal of Neuroscience 1993, 13:1879-1887.
11. Fisher M., Bastan B. Treating acute ischemic stroke. Current Opinion in Drug Discovery and Development 2008, 11:626-632.
12. 2+ channel subtypes expressed in Xenopus oocytes. Journal of Pharmacology and Experimental Therapeutics 1999, 291:464-473.
13. Ginsberg M.D. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 2009, 40:S111-S114.
14. Goldberg M.P., Choi D.W. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. Journal of Neuroscience 1993, 13:3510-3524.
15. Horn J., de Haan R.J., Vermeulen M., Luiten P.G., Limburg M. Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke 2001, 32:2433-2438.
16. Jiang H., Zhang L., Koubi D., Kuo J., Groc L., Rodriguez A.I., Hunter T.J., Tang S., Lazarovici P., Gautam S.C., Levine R.A. Roles of Ras-Erk in apoptosis of PC12 cells induced by trophic factor withdrawal or oxidative stress. Journal of Molecular Neuroscience 2005, 25:133-140.
17. Kaspler P., Horowitz M. Heat acclimation and heat stress have different effects on cholinergic-induced calcium mobilization. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 2001, 280:R1688-R1696.
18. Kaste M., Fogelholm R., Erila T., Palomaki H., Murros K., Rissanen A., Sarna S. A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke 1994, 25:1348-1353.
19. 2+ channel antagonists and neuroprotection from cerebral ischemia. European Journal of Pharmacology 1998, 363:1-15.
20. LoPachin R.M., Gaughan C.L., Lehning E.J., Weber M.L., Taylor C.P. Effects of ion channel blockade on the distribution of Na, K, Ca and other elements in oxygen-glucose deprived CA1 hippocampal neurons. Neuroscience 2001, 103:971-983.
21. Lyden P., Wahlgren N.G. Mechanisms of action of neuroprotectants in stroke. Journal of Stroke Cerebrovascular Diseases 2000, 9:9-14.
22. Michaeli A., Yaka R. Dopamine inhibits GABA(A) currents in ventral tegmental area dopamine neurons via activation of presynaptic G-protein coupled inwardly-rectifying potassium channels. Neuroscience 2010, 165:1159-1169.
23. Nag D., Garg R.K., Varma M. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke. Indian Journal of Physiology and Pharmacology 1998, 42:555-558.
24. No authors listed Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Trust Study Group. Lancet 1990, 336:1205-1209.
25. Perlman J.M. Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clinical Therapeutics 2006, 28:1353-1365.
26. 2+ rise induced by oxygen/glucose deprivation in cortical neurons. Stroke 1998, 29:196-201. discussion 202.
27. Rahbar-Roshandel N., Razavi L., Tavakoli-Far B., Mahmoudian M. Mebudipine and dibudipine protect PC12 cells against oxygen-glucose deprivation and glutamate-induced cell death. Pathophysiology 2008, 15:227-231.
28. Tabakman R., Jiang H., Levine R.A., Kohen R., Lazarovici P. Apoptotic characteristics of cell death and the neuroprotective effect of homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. Journal of Neuroscience Research 2004, 75:499-507.
29. Tabakman R., Jiang H., Schaefer E., Levine R.A., Lazarovici P. Nerve growth factor pretreatment attenuates oxygen and glucose deprivation-induced c-Jun amino-terminal kinase 1 and stress-activated kinases p38alpha and p38beta activation and confers neuroprotection in the pheochromocytoma PC12 Model. Journal of Molecular Neuroscience 2004, 22:237-250.
30. Tabakman R., Jiang H., Shahar I., Arien-Zakay H., Levine R.A., Lazarovici P. Neuroprotection by NGF in the PC12 in vitro OGD model: involvement of mitogen-activated protein kinases and gene expression. Annals of the New York Academy of Sciences 2005, 1053:84-96.
31. Tabakman R., Lazarovici P., Kohen R. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. Journal of Neuroscience Research 2002, 68:463-469.
32. Zhu X.L., Xiong L.Z., Wang Q., Liu Z.G., Ma X., Zhu Z.H., Hu S., Gong G., Chen S.Y. Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats. Neuroscience Letters 2008.
33. Zipfel G.J., Babcock D.J., Lee J.M., Choi D.W. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. Journal of Neurotrauma 2000, 17:857-869.